Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Nature Reviews. Rheumatology
|
March 27, 2025
Imaging inflammation with leukocyte-targeted PET tracers
Filippo Fagni
The New England Journal of Medicine
|
March 5, 2020
Nasal Deformity in Granulomatosis with Polyangiitis
Federica Bello, Filippo Fagni
Rheumatology (Oxford, England)
|
October 14, 2021
Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?
Filippo Fagni, David Simon
Annals of the Rheumatic Diseases
|
May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis
David Simon, Filippo Fagni, Georg Schett
Internal and Emergency Medicine
|
January 1, 2021
ANCA testing: where are we now?
Milena Bond, Filippo Fagni, Augusto Vaglio
Frontiers in Medicine
|
March 15, 2021
Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology
Filippo Fagni, Federica Bello, Giacomo Emmi
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 2, 2021
Reply
David Simon, Filippo Fagni, Koray Tascilar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2023
Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
Filippo Fagni, Francesca Motta, Georg Schett, et al.
Cytokine & Growth Factor Reviews
|
July 27, 2024
Targeting cytokines in psoriatic arthritis
Laura Neurath, Michael Sticherling, Georg Schett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 12, 2022
Reply
Georg Schett, David Simon, Filippo Fagni, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Nature Reviews. Rheumatology
|
March 27, 2025
Imaging inflammation with leukocyte-targeted PET tracers
Filippo Fagni
The New England Journal of Medicine
|
March 5, 2020
Nasal Deformity in Granulomatosis with Polyangiitis
Federica Bello, Filippo Fagni
Rheumatology (Oxford, England)
|
October 14, 2021
Long-term treatment in rheumatoid arthritis: do biological and targeted-synthetic DMARDs increase the risk of malignancy?
Filippo Fagni, David Simon
Annals of the Rheumatic Diseases
|
May 5, 2022
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis
David Simon, Filippo Fagni, Georg Schett
Internal and Emergency Medicine
|
January 1, 2021
ANCA testing: where are we now?
Milena Bond, Filippo Fagni, Augusto Vaglio
Frontiers in Medicine
|
March 15, 2021
Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology
Filippo Fagni, Federica Bello, Giacomo Emmi
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 2, 2021
Reply
David Simon, Filippo Fagni, Koray Tascilar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 18, 2023
Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach
Filippo Fagni, Francesca Motta, Georg Schett, et al.
Cytokine & Growth Factor Reviews
|
July 27, 2024
Targeting cytokines in psoriatic arthritis
Laura Neurath, Michael Sticherling, Georg Schett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 12, 2022
Reply
Georg Schett, David Simon, Filippo Fagni, et al.
Page
of 7